Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Wednesday, May 20, 2026

Snapshot: May 20, 2026 · 6:00 PM 100 stocks analyzed

Strong Up Day

Wed, May 20, 2026 Small-Cap Rally High

Small caps surged 2.6% to lead a broad rally, with Russell 2000 vastly outpacing mega-cap tech as 31% of gainers clustered in healthcare and high dispersion gripped individual n…

60% Small-cap leadership dominated the day: Russell 2000 jumped 2.56%, crushing the S&P 500's 1.08% gain and NASDAQ's 1.54% move, confirming a genuine rotation away from mega-cap tech into beaten-down micro and mid-caps with extreme single-stock dispersion (top gainer HCWB +129%, five healthcare debutants, healthcare accounting for 31% of gainers). VIX fell 3.4%, underpinning risk-on sentiment.
25% News-grounded catalysts drove a cluster of outsized movers: GCL (+72% on ADATA investment), IMVT (+35% on positive Phase 2 rheumatoid arthritis trial), CAPS (+26% on 60% revenue growth), TNMG (+30% on AI advertising launch), and TE (+26% on $13.7B hedge fund accumulation) all showed tangible fundamental triggers, anchoring the broader dispersion narrative in real events rather than pure speculation.
15% Persistent losers and sector imbalance signaled ongoing bifurcation: WOK extended a six-day losers streak, LICN collapsed 61% (no catalyst found), and tech comprised 24% of losers even as healthcare dominated gainers, reflecting aggressive rotation out of large-cap software and semiconductors into clinical-stage biotech and small-cap thematic plays on AI, quantum, and energy.

Healthcare drove 31% of gainers WOK on a 6-day losers streak 5 names returned after long absences WOK · 6-day losers streak LICN · 3-day losers streak GCL — first appearance

Market Regime

Wed, May 20, 2026 Neutral conf: high macro · prototype

+19

Tailwind −100 … +100 · + tailwind / − headwind

VIX17.4 p54 Drawdown-0.9% Held4d · building SinceMay 15

Top drivers: S&P vs 50d avg ▲ S&P 20d return ▲ Small-cap leadership ▼

processId: history-market-regime

Market Indexes

Wed, May 20, 2026 4

S&P 500

7,432.77

+79.16

+1.08%

NASDAQ Composite

26,270.36

+399.65

+1.54%

Russell 2000

2,817.36

+70.29

+2.56%

VIX

17.44

−0.62

-3.43%

Biggest Gainers

Wed, May 20, 2026 50

HCWB

HCW Biologics Inc.Healthcare

$2.43+$1.37

+129.2%

NASDAQ · Mkt cap $3.7 M

No news headlines were available in the last 48 hours to explain HCWB's 129% gain, so the catalyst remains unknown; the move may reflect delayed news dissemination, a clinical trial result, or technical trading activity.

Yahoo Finance returned no headlines for HCW Biologics in the 48-hour window around this massive 129% single-day jump, which is unusual for the 1 gainer on a major exchange. This absence could mean several things: the triggering event occurred before the 48-hour window, news sources have not yet indexed it, or the move was driven by non-public-market factors. For a small-cap biotech stock like HCWB, typical catalysts that produce triple-digit moves include positive clinical trial announcements, FDA approvals or breakthrough designations, partnership deals, or significant insider transactions. The absence of headline evidence prevents attribution to any specific event. Retail interest, short squeezes, or technical breakouts can also drive sharp moves in low-float biotech names, though these tend to be self-reinforcing rather than fundamentally grounded.

SLXN

Silexion Therapeutics Ltd.Healthcare

$0.53+$0.26

+97.0%

NASDAQ · Mkt cap $540 K

No news headlines are available for Silexion in the past 48 hours, so the 97% gain cannot be attributed to a disclosed catalyst. The move likely reflects a technical or sentiment-driven event typical of small-cap biotech stocks.

The absence of recent news headlines makes it impossible to identify a specific corporate catalyst for the nearly 97% single-day jump. Silexion is a small-cap therapeutic company trading at $0.53, a price point and market segment that typically exhibits high volatility. Possible explanations include a delayed news release not yet indexed by the RSS feed, technical short covering or squeeze activity in a thinly traded name, insider or institutional buying based on unreported developments, or pure sentiment shift driven by sector rotation or social media discussion. Without access to company filings, press releases, or clinical trial announcements released outside the 48-hour window, any specific explanation would be speculation. The stock's ranking as the second-largest gainer suggests broad market awareness of the move, which typically follows material events, but those events are not documented in the provided headlines.

GCL

GCL Global Holdings Ltd Ordinary SharesCommunication Services

$0.74+$0.31

+72.5%

NASDAQ · Mkt cap $74 M

GCL surged 72% following announcement of an expanded strategic investment from ADATA Technology, signaling accelerated growth prospects in games and entertainment via its 4Divinity publishing subsidiary.

On May 19, GCL announced a major strategic investment from ADATA Technology intended to accelerate global entertainment and digital growth through its 4Divinity publishing subsidiary. The headline fragment provided does not specify investment size, terms, or detailed strategic rationale, but the timing aligns perfectly with the stock's 72% jump on May 20. For a micro-cap gaming and entertainment company trading near $0.74, an announced capital infusion and partnership with a larger technology player typically signals both fresh capital and validation of business model, both of which drive sharp single-day rallies. The stock's rank as the third-largest gainer on the day suggests broad market recognition of the announcement's positive implications for growth and financial runway.

PHGE

BiomX Inc.Industrials

$0.60+$0.22

+59.6%

AMEX · Mkt cap $1.5 M

No news headlines were published in the last 48 hours, so the 59.6% gain cannot be attributed to any reported event or announcement; the cause likely involves technical trading, delayed news pickup, or unconfirmed rumors in micro-cap biotechnology.

BiomX Inc. is a micro-cap biotech stock trading at $0.60, and despite a dramatic 59.6% single-day gain placing it in the top 4 gainers, no financial news appeared in the last 48 hours on Yahoo Finance. For a stock at this price and market cap, such moves typically reflect one of several non-news drivers: short squeeze or covering activity among retail or algorithmic traders, technical bounce off support levels after extended declines, delayed pickup of older announcements not yet indexed by major news feeds, unconfirmed rumors circulating on social media or trading forums, or rebalancing activity in penny-stock indices. Given the silence on traditional channels and the speculative nature of the security, inference around structural catalysts is limited. Without access to insider trading data, short interest levels, or volume analysis, the specific mechanism remains opaque.

MTVA

MetaVia Inc.Healthcare

$2.89+$1.01

+53.7%

NASDAQ · Mkt cap $7.6 M

MetaVia announced publication of peer-reviewed research supporting the anti-fibrotic potential of its MASH drug candidate Vanoglipel on May 20, likely driving the 53.7% intraday surge in this clinical-stage biotech stock.

MetaVia released news on the morning of May 20 highlighting a peer-reviewed publication supporting preclinical anti-fibrotic data for Vanoglipel, its clinical-stage candidate for MASH (metabolic dysfunction-associated steatohepatitis). For early-stage biotech companies with no approved products, positive clinical or preclinical data publications can materially move sentiment and stock price, particularly if the data strengthens confidence in pipeline assets ahead of human trials or regulatory milestones. The timing of the announcement on the same day as the 53.7% gain, combined with the absence of any contradictory or offsetting news, suggests this publication was the primary catalyst. The broader healthcare sector also gained modestly on May 19, which may have provided modest tailwinds, but the magnitude of MTVA's move far exceeds sector momentum.

MWC

Micware Co., Ltd. American Depositary SharesConsumer Cyclical

$7.15+$2.43

+51.5%

NASDAQ · Mkt cap $88 M

No news headlines appeared in the last 48 hours to explain MWC's 51.48% jump on May 20, 2026, so the catalyst remains unknown; the move likely stems from a technical, rumor-based, or delayed news event not captured in this feed.

The absence of recent news headlines creates significant ambiguity about the cause of this large single-day gain. A 51% intraday move in a microcap depositary share typically signals either material new information, a short squeeze, or a substantial technical reversal. Without headlines, the most probable explanations fall into a few categories: a delayed or embargoed press release that broke after news cycles, an earnings surprise or guidance revision, a corporate action affecting the ADR structure, or accumulation by larger holders triggering technical breakouts. Microcap ADRs are also prone to thin liquidity, meaning even moderate institutional buying can generate outsized percentage moves. The absence of confirmatory news suggests either the catalyst has not yet been publicly disseminated to major financial wires, or the move originated from trading activity rather than a discrete corporate event.

AREB

American Rebel Holdings, Inc.Consumer Cyclical

$0.06+$0.02

+48.3%

NASDAQ · Mkt cap $4.8 M

American Rebel Holdings CEO announced Capitol Hill meetings, a Total Wine partnership expansion, and advancing national brand momentum for American Rebel Light Beer, signaling offensive growth strategy that likely drove the 48% intraday surge in this penny stock.

The May 20 headline announcing CEO Andy Ross's Washington DC activities, government relationships, industry partnerships, and specifically a Total Wine partnership advance directly addresses distribution and retail shelf space expansion for the company's flagship light beer product. For a micro-cap stock trading at $0.06, concrete news about partnership expansion and national visibility typically catalyzes speculative buying. The timing of the press release at 12:00 UTC aligns with the large same-day gain. The secondary headline about Champion Safe Company's charitable partnership appears unrelated to AREB's core beer business unless Champion Safe is a subsidiary or related entity, which the provided information does not establish. The gain is substantial but the absolute price remains extremely low, consistent with penny-stock volatility where even modest volume shifts can produce outsized percentage moves.

PETZ

TDH Holdings, Inc.Real Estate

$1.15+$0.34

+42.0%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 42% jump in PETZ stock cannot be attributed to any publicly reported catalyst. The move likely reflects technical trading, retail interest, or unconfirmed rumors in this highly volatile microcap security.

The absence of any recent news headlines in the Yahoo Finance RSS feed means we cannot point to a specific corporate event, earnings surprise, regulatory action, or business development as the cause of today's 41.98% gain. PETZ is a microcap stock trading at $1.15, which typically exhibits high volatility and can be susceptible to momentum trading, short squeezes, or algorithmic buying. Stocks in this price range and market cap tier are often driven by technical factors—breakouts from prior resistance, options expiry effects, or broader retail trading sentiment—rather than fundamental news. Another possibility is that a material announcement was made outside the Yahoo Finance RSS feed or has not yet been widely indexed. Without access to the company's investor relations page, SEC filings, or alternative news sources, we cannot rule out a real development that simply hasn't yet appeared in the headline feed captured here.

MLGO

MicroAlgo Inc.Technology

$5.36+$1.53

+39.9%

NASDAQ · Mkt cap $47 M

MicroAlgo announced a quantum image edge extraction algorithm for noisy images on May 20, which likely catalyzed the 40% single-day surge as the market reacted positively to the technical innovation claim.

The company disclosed development of a quantum image edge extraction algorithm, described as an "innovative achievement of the deep integration" of quantum computing and image processing. This is a science and technology announcement that directly preceded the stock's ninth-place ranking among daily gainers. However, the news snippet provided is incomplete, cutting off mid-sentence, so the full scope of the achievement, commercial application timeline, partnership details, or revenue implications remain unknown. For a micro-cap stock trading at $5.36, investor sentiment can swing sharply on technical breakthroughs in emerging fields like quantum computing, even when commercial viability or revenue impact is years away. The timing of the announcement (same day as the price move) and the magnitude of the gain suggest the market is pricing in genuine optimism about the company's quantum computing capabilities or potential licensing/partnership value, though investors should note the incomplete headline limits certainty about what exactly was announced.

EMISR

Emmis Acquisition Corp. Rights

$0.14+$0.04

+39.9%

NASDAQ

No news headlines were found in the last 48 hours, so the 39.86% gain in EMISR cannot be directly attributed to a specific event. The move likely reflects either technical trading activity, a delayed market reaction, or shifts in the underlying SPAC warrant or rights situation.

Emmis Acquisition Corp. Rights (EMISR) is a SPAC-related security, specifically the rights component of a special purpose acquisition vehicle. These instruments are highly sensitive to redemption dynamics, merger probability reassessments, and shifts in investor sentiment toward the blank-check entity or its announced target. Without news headlines to anchor the analysis, the 39.86% single-day jump could stem from several structural factors common to SPAC rights: a positive update on merger negotiations that has not yet reached broad press coverage, changes in redemption expectations, technical short-covering in a thinly traded security, or updated guidance on deal terms. Rights offerings are inherently volatile and trade on forward expectations rather than fundamentals, making them prone to sharp moves on low volume. The absence of any recent headline coverage does not mean no catalyst occurred—it may simply indicate the news has not yet been widely distributed or picked up by major financial RSS feeds.

IMVT

Immunovant, Inc.Healthcare

$35.56+$9.27

+35.3%

NASDAQ · Mkt cap $8.1 B

Immunovant surged 35% after releasing positive Phase 2 trial results for IMVT-1402 in difficult-to-treat rheumatoid arthritis, with response rates analysts called "highly compelling" and "clinically meaningful."

On May 20, 2026, Immunovant reported fourth-quarter earnings alongside clinical trial data for its lead drug candidate IMVT-1402 targeting difficult-to-treat rheumatoid arthritis. The trial demonstrated response rates of 72.7% ACR20, 54.5% ACR50, and 35.8% ACR70 at Week 16 in open-label assessment. Multiple headlines emphasize that financial analysts deemed these results "highly compelling" and "clinically meaningful," language typically reserved for data that supports advancement toward commercialization or regulatory approval. The company also reported a strengthened balance sheet following a settlement. The stock hit a two-year high, indicating investor conviction that these trial results materially increase the probability of eventual approval and commercial success. The stock rallied despite missing on earnings, underscoring that trial efficacy data dominated investor sentiment on the day.

RAIN

Rain Enhancement Technologies Holdco IncIndustrials

$2.02+$0.52

+34.7%

NASDAQ · Mkt cap $10 M

No news headlines were available in the last 48 hours, so the 34.67% gain appears driven by factors other than public company announcements, likely technical or speculative trading activity in a low-priced stock.

The absence of news coverage in Yahoo Finance's RSS feed over the past 48 hours means we cannot attribute this sharp move to earnings releases, product announcements, regulatory actions, or strategic changes. Rain Enhancement Technologies is a micro-cap stock trading at $2.02, a price point where retail trading, short-covering, and technical momentum tend to have outsized influence. The stock's ranking as the 12th biggest gainer today, combined with no identifiable catalyst, suggests the move may stem from technical buying (e.g., a break above a resistance level, moving average crossover), short-squeeze dynamics, or speculative interest rather than fundamental news. Without access to volume data, insider activity, or social media sentiment, the precise trigger remains unclear, though these dynamics are typical for low-float, low-priced names.

QUCY

Mainz Biomed N.V.Healthcare

$3.35+$0.83

+32.9%

NASDAQ · Mkt cap $15 M

QUCY surged 33% on three defense-focused patent filings by Quantum Cyber in the past 48 hours, covering quantum navigation, EMP shielding, and autonomous mine countermeasure systems aligned with Trump administration priorities.

The three patent announcements from Quantum Cyber released on May 19-20 address high-profile defense gaps: autonomous amphibious platforms with GPS-denied navigation, EMP-hardened drone electronics, and naval mine countermeasures targeting Iran's Strait of Hormuz threats. All three filings emphasize alignment with current U.S. administration defense and homeland security priorities, which may have resonated with defense-focused investors. However, it is important to note that provisional and non-provisional patent filings do not guarantee commercialization, revenue, or market adoption. The move appears driven by investor enthusiasm for the company's defense technology pipeline rather than any concrete contract award or revenue announcement. The timing during an administration focused on defense spending may have amplified the positive sentiment.

JDZG

JIADE LimitedConsumer Defensive

$3.14+$0.77

+32.5%

NASDAQ · Mkt cap $23 M

No news headlines were found in the last 48 hours, so the 32.49% jump in JDZG cannot be attributed to a specific announced event; the move likely reflects technical trading, delayed news pickup, or market speculation.

Yahoo Finance returned zero headlines for JDZG in the 48 hours preceding this snapshot. Without reported earnings, guidance changes, regulatory actions, or material announcements, it is impossible to ground the move in documented corporate news. A 32.49% single-day gain in a lower-priced NASDAQ stock ranking as the 14th biggest gainer suggests several uninformed possibilities: short covering if the stock has high short interest, retail buying momentum or social media attention, technical bounce off support, delayed dissemination of news not yet captured in major feeds, or a low-volume spike that amplified normal trading. Without additional context on the stock's fundamentals, float, or recent price history, any specific claim would be speculation rather than inference.

CTEV

Claritev CorporationHealthcare

$21.24+$5.04

+31.1%

NYSE · Mkt cap $662 M

A 31% single-day jump in CTEV lacks supporting news in the provided headlines. The partial healthcare sector update is unrelated to the stock's outsized move, making the catalyst unclear without additional information.

The news snippet provided is a generic sector update noting that healthcare stocks advanced late Monday afternoon, with no mention of Claritev Corporation specifically. This sector-level observation does not explain a 31% single-day gain ranking among the top 15 gainers of the day, which would require company-specific positive catalysts. Possible drivers for this magnitude of move typically include earnings beats, FDA approvals or clinical trial results for biotech firms, merger or acquisition announcements, insider buying signals, or significant short squeeze activity. Without headlines directly addressing Claritev's fundamentals or corporate actions, the root cause cannot be established from the evidence provided. The timing lag between the sector update (May 18) and the price snapshot (May 20) further suggests the catalyst may have emerged after the provided headlines were published.

ARMG

Leverage Shares 2x Long ARM Daily ETF

$24.41+$5.69

+30.4%

NASDAQ

No news headlines were found in the last 48 hours, but ARMG is a 2x leveraged long ARM ETF, so a +30.40% gain likely reflects a strong move in the underlying ARM Holdings stock, which would be amplified by the 2x leverage structure.

The absence of any news headlines for ARMG itself over the last 48 hours makes direct attribution impossible. However, ARMG is a daily reset leveraged ETF that tracks ARM Holdings with 2x long exposure, meaning its daily returns are designed to be approximately double the daily returns of ARM. A +30.40% move in ARMG would imply roughly a +15% move in ARM Holdings on the snapshot date. This could reflect a major positive announcement affecting ARM (earnings beat, new partnership, guidance raise, market share gains, or sector strength in semiconductor/IP licensing), a short squeeze, or broad market momentum in the technology sector. Without ARM-specific headlines available, the actual catalyst driving ARM higher cannot be identified from the provided evidence.

TNMG

TNL MediageneCommunication Services

$0.78+$0.18

+29.9%

NASDAQ · Mkt cap $1.1 M

TNL Mediagene subsidiary Ad2iction launched an upgraded AI advertising solution integrating retail transaction and intent signals, likely driving investor optimism about the company's competitive positioning in AI-driven advertising.

The headline establishes that Ad2iction announced a product upgrade centered on predictive AI audience modeling designed to support the shift away from tracking-based advertising toward AI search. This is positioned as a strategic response to industry trends toward privacy-focused, data-driven advertising solutions. The timing of the nearly 30 percent gain on the same day as the announcement suggests the market viewed this product launch as meaningful progress on the company's AI capabilities and market relevance. However, the headline excerpt is truncated and does not provide specifics on revenue impact, market size, customer adoption timelines, or competitive differentiation metrics that would normally justify such a sharp move. The gain may reflect relief or renewed confidence in the company's direction after a period of uncertainty, or it could reflect anticipation of near-term customer wins.

CCTG

CCSC Technology International Holdings Limited Ordinary SharesIndustrials

$0.59+$0.13

+28.2%

NASDAQ · Mkt cap $8.8 M

No headlines were found in the last 48 hours to explain the 28.21% intraday gain in CCTG. The move likely reflects technical trading, a delayed news release, or market sentiment shift in a low-liquidity micro-cap stock.

Zero headlines are available from Yahoo Finance in the last 48 hours surrounding this gain, making direct attribution impossible. CCSC Technology International Holdings Limited is a micro-cap stock trading at $0.59, which typically exhibits higher volatility and is more susceptible to technical factors such as short covering, momentum trading, or retail buying activity. Without access to press releases, insider filings, or earnings announcements, the most probable generic categories are: first, a delayed or embargoed news announcement not yet reflected in the RSS feed; second, technical or momentum-driven buying in a thinly traded security; or third, sector-level bullish sentiment affecting Chinese or technology holdings. None of these can be confirmed from the evidence at hand.

BTM

Bitcoin Depot Inc.Financial Services

$0.72+$0.16

+27.5%

T1 Energy IncIndustrials

$8.70+$1.82

+26.5%

NYSE · Mkt cap $1.3 B

A $13.7 billion hedge fund acquired 10 million shares of T1 Energy on May 19, triggering a 23% surge that day; the stock continued rallying on May 20 to close up 26.45%, likely sustained by follow-on buying momentum and investor enthusiasm from the large institutional accumulation.

The primary catalyst is the headline from May 19 reporting that a mega hedge fund with $13.7 billion in assets purchased 10 million shares of TE, pushing the stock up 23.46% that day. The May 20 gain of an additional 3.19% points (from $7.00 to $8.70) appears to be continuation of that momentum, as institutional buying of this magnitude often attracts retail followers and triggers short covering in smaller-cap names. The first headline mentioning TE as trading below estimated value in May 2026 provides some fundamental support for the thesis that the stock was undervalued, lending credibility to the hedge fund's accumulation decision. No material news about earnings, contracts, or company-specific developments is present, so the move is driven by demand-side factors rather than new information about TE's business itself.

DMRC

Digimarc CorporationTechnology

$12.05+$2.51

+26.3%

NASDAQ · Mkt cap $169 M

No news headlines were found in the last 48 hours, so the 26.31% gain cannot be attributed to a specific announced event. The jump likely stems from technical momentum, delayed news pickup, or market rumors.

Digimarc (DMRC) jumped 26.31% on May 20, 2026, but no recent news headlines are available to explain the move. This creates a gap between price action and transparent catalyst. Digimarc is a small-cap security focused on digital identification, watermarking, and supply chain solutions, sectors that can be sensitive to contract wins, product announcements, or industry tailwinds in authentication and anti-counterfeiting. Without headline evidence, the move could reflect several possibilities: a delayed news story not yet picked up by Yahoo Finance RSS, short covering or technical momentum among retail traders, analyst upgrades not yet public, or early-stage rumors about partnerships or enterprise deals. The stock's relatively low price point and small float may amplify such moves. Without corroborating news, we cannot pinpoint the specific catalyst.

HYFT

MindWalk Holdings Corp.Healthcare

$1.59+$0.33

+26.2%

CAPS

Capstone Holding Corp.Basic Materials

$0.39+$0.08

+26.1%

NASDAQ · Mkt cap $2.9 M

Capstone reported Q1 2026 earnings on May 20 showing 60% revenue growth and 124% gross profit growth with best gross margin in four years, directly spurring the 26% intraday gain.

The earnings release issued this morning (2026-05-20 11:35 UTC) disclosed strong top-line and bottom-line performance that materially exceeded typical expectations for a building products distributor. Revenue growth of 60% year-over-year combined with gross profit expansion of 124% and margin improvement to a four-year high suggests both robust demand and operational leverage. For a micro-cap stock trading at $0.39, positive earnings surprises of this magnitude—particularly when they demonstrate margin expansion rather than just topline growth—typically trigger substantial single-day rallies as institutional and retail investors reassess the company's trajectory. The timing of the release (during market hours) enabled immediate price discovery. No conflicting news or guidance cuts were mentioned, so the move appears cleanly attributable to the earnings beat itself.

STFS

Star Fashion Culture Holdings LimitedCommunication Services

$9.46+$1.95

+26.0%

NASDAQ · Mkt cap $5.3 M

No news headlines were found in the last 48 hours for STFS, so the 26% gain likely stems from technical factors, delayed announcements, or untracked social media activity rather than a documented corporate event.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to identify a specific news catalyst for this 25.97% jump. STFS is a micro-cap fashion retail stock, which typically exhibits higher volatility and can be susceptible to technical rallies, short covering, retail trading coordination on social platforms, or delayed earnings releases not yet indexed by major news aggregators. Another possibility is that the stock recovered from an earlier decline on anticipated positive results or insider activity, though without access to SEC filings or real-time market commentary, this remains speculative. The lack of corroborating headlines suggests either the move preceded major news dissemination or was driven by sentiment rather than a specific disclosed event.

WETO

Webus International Limited Ordinary SharesTechnology

$0.73+$0.15

+24.8%

NASDAQ · Mkt cap $11 M

Webus (WETO) surged 24.83% following a Wetour Robotics announcement demonstrating a cross-device AI agent interface using a Conductor sEMG wristband to control IoT devices, PCs, and AR glasses via an Orchestra Edge AI Hub, positioning the company in the emerging agent-centric computing shift.

The single headline provided describes a product demonstration by Wetour Robotics showcasing advanced wearable and edge AI technology aligned with industry trends toward agent-centric computing as articulated by Qualcomm leadership. The announcement highlights a touchless control interface across multiple device categories, which represents a differentiated technology narrative in the competitive wearable and IoT space. This type of product milestone or partnership demonstration typically attracts investor enthusiasm for micro-cap stocks trading at low absolute prices, especially when framed around emerging tech categories like AI agents and edge computing. The 24.83% single-day gain is consistent with retail or momentum-driven interest in small-cap technology stories, though without broader context on cash position, revenue scale, or competitive standing, the durability of the move remains uncertain.

NCPL

Netcapital Inc.Financial Services

$0.45+$0.09

+24.0%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the 24% gain in NCPL stock likely reflects technical trading activity, delayed news digestion, or market rumors rather than any identifiable corporate announcement.

The absence of any news coverage in the last 48 hours makes it impossible to pinpoint a specific catalyst for the 24% intraday jump. Netcapital is a microcap alternative investment platform, and stocks in this category are often subject to sharp price swings driven by retail trading momentum, short covering, or delayed market reaction to older announcements that may not have immediate press coverage. Without access to SEC filings, social media activity, or direct company statements on 2026-05-20, reasonable possibilities include a previously announced financing round gaining traction, technical momentum off a low base, or speculative positioning in a thinly traded security. The lack of headlines does not mean nothing happened; it may simply mean the catalyst was not widely reported by major financial news outlets within the RSS feed window provided.

OKLL

Daily Target 2X Long OKLO ETF

$7.81+$1.51

+24.0%

NASDAQ

No news headlines were found in the last 48 hours, but OKLL is a 2X leveraged long ETF tracking OKLO (a nuclear energy company), so a ~12% gain in the underlying would mechanically produce roughly a 24% gain in the ETF, suggesting strong movement in nuclear or clean energy equities.

The absence of news in the provided headlines makes it impossible to pinpoint a specific catalyst for this move. However, OKLL's structure as a daily target 2X leveraged long ETF means it amplifies moves in its underlying asset by approximately two times. The nearly 24% gain suggests the underlying OKLO stock rose roughly 12% on May 20, 2026. This type of move in a nuclear energy company could stem from several categories: positive sentiment in the nuclear or clean energy sector broadly, company-specific developments not yet reflected in the news feed, technical momentum or short covering, or macro shifts favoring nuclear as an energy solution. Without access to news on the underlying OKLO or sector trends, we cannot distinguish between these possibilities. The gain magnitude is consistent with either sector enthusiasm or a discrete company event.

FRGT

Freight Technologies, Inc.Technology

$4.00+$0.76

+23.5%

NASDAQ · Mkt cap $1.0 M

No news headlines were found in the last 48 hours covering FRGT, so the 23.46% gain likely reflects technical trading, a delayed announcement, or sector momentum rather than a publicly reported event.

The absence of recent news headlines is the key observation here. FRGT jumped nearly a quarter in value on a day when no identifiable catalyst appears in the Yahoo Finance RSS feed. For a smaller-cap freight technology stock, a move of this magnitude without accompanying news coverage suggests several possibilities. The jump could reflect short covering or technical bounce-back after prior weakness, sector rotation into freight or logistics stocks, an after-hours or pre-market announcement not yet indexed by the news feed, institutional accumulation, or reaction to a press release issued directly by the company but not yet widely syndicated. Freight technology stocks can be volatile, and without concrete information, we cannot distinguish between legitimate business developments and pure momentum trading.

ORBS

Eightco Holdings Inc.Consumer Cyclical

$0.90+$0.17

+23.3%

NASDAQ · Mkt cap $257 M

No relevant news about ORBS was provided in the 48-hour window. The 23.30% gain likely reflects a technical bounce, short covering, or delayed market reaction to an unrelated corporate event.

The single headline in the news feed concerns BitMine Immersion Technologies and Ethereum pricing dynamics, which has no connection to ORBS (Eightco Holdings Inc.). ORBS is a micro-cap stock trading at $0.90, and such securities are prone to sharp percentage moves on modest volume, short squeezes, or company-specific announcements not captured in this particular news feed. Without relevant headlines, the driver remains unclear. Possible categories include a delayed earnings release, a small M&A or financing announcement, short covering in a thinly traded security, or simply technical mean-reversion after prior weakness. The gap between the news provided and the stock's movement suggests either the catalyst occurred outside the monitored news window or was distributed through channels other than the Yahoo Finance RSS feed used here.

RANI

Rani Therapeutics Holdings, Inc.Healthcare

$1.09+$0.21

+23.2%

NASDAQ · Mkt cap $126 M

No news headlines were found in the last 48 hours, so the 23.25% jump in RANI stock cannot be attributed to a specific announced event; the move likely reflects technical trading, delayed news pickup, or market sentiment shifts in the small-cap biotech space.

Rani Therapeutics is a clinical-stage biopharmaceutical company with a market cap typically under $100 million, making it highly sensitive to technical factors, short-covering, and retail trading interest. The absence of news in the prior 48 hours suggests the catalyst was either not captured by the RSS feed, originated earlier and is now being repriced, or is purely technical in nature. Small-cap biotech stocks frequently experience large single-day moves on momentum, options activity, or sector rotation independent of company-specific announcements. Without access to intraday volume data, social media chatter, options flow, or delayed press release timing, it is not possible to identify the specific trigger with confidence.

RGNT

Regentis Biomaterials Ltd.Healthcare

$2.28+$0.41

+22.2%

AMEX · Mkt cap $16 M

No news headlines were found in the last 48 hours to explain the 22.25% gain in RGNT. The jump was likely driven by a technical catalyst, delayed news publication, or market rumor not captured in the available feeds.

Regentis Biomaterials is a small-cap biotech firm trading on AMEX, and the lack of recent news coverage makes direct causation impossible to establish from the provided sources. However, small-cap biotech stocks are particularly sensitive to several non-news catalysts: short covering (if the stock has significant short interest), options expiration mechanics on a light trading day, or a delayed announcement that has not yet been syndicated to Yahoo Finance RSS. It is also possible that news broke after market close on May 19 or early on May 20, creating a gap-up open. Without access to the company's investor relations page, SEC filings, or real-time trading data, we cannot distinguish between these scenarios.

MEHA

Functional Brands, Inc. Common StockConsumer Defensive

$0.09+$0.02

+22.0%

NASDAQ · Mkt cap $177 K

No news headlines were found in the last 48 hours, so the 21.95% gain in MEHA stock likely reflects technical trading, short covering, or an undisclosed catalyst not captured by the major news feeds.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for this jump. MEHA is a micro-cap stock trading at $0.09, which typically exhibits higher volatility and is more susceptible to technical factors, retail trading activity, and momentum plays. Possible explanations include short squeeze activity as traders cover underwater positions, algorithmic or technical breakouts triggering buying, delayed dissemination of company announcements through non-RSS channels, or sentiment shifts in small-cap equity communities. Without confirmed news, attributing the move to any particular business development would be speculation.

CDLX

Cardlytics, Inc.Communication Services

$0.73+$0.13

+21.7%

NASDAQ · Mkt cap $24 M

Lake Street's $1.25 price target on May 19 likely catalyzed the 21.66% jump, as the target—though reduced—still implies 71% upside from the pre-announcement price, signaling analyst confidence in recovery despite lowered near-term expectations.

The headline reports that Lake Street Capital cut its price target for Cardlytics to $1.25 amid "reset expectations," suggesting the firm had previously held a higher target and is now recalibrating. The article also notes that Cardlytics qualifies as a best penny stock according to hedge funds, which may have attracted retail attention. A $1.25 target on a stock trading near $0.60 before the move implies meaningful upside potential. In penny stocks, even modest analyst actions can drive outsized moves due to thin float and high retail interest. This is not a negative catalyst dressed as positive; rather, it appears to be an analyst repricing that, despite being a "cut," still maintains a constructive stance. The timing and classification alongside other penny-stock gainers suggests this was the primary driver.

PPSI

Pioneer Power Solutions, Inc.Industrials

$4.85+$0.86

+21.6%

NASDAQ · Mkt cap $34 M

No news headlines were published in the last 48 hours, so the 21.55% jump cannot be attributed to a specific reported event. The move may reflect technical factors, delayed market reaction to earlier developments, or untracked catalysts.

The absence of recent news headlines makes it difficult to pinpoint the exact driver of PPSI's strong gain. Pioneer Power Solutions is a smaller-cap industrial equipment and power solutions company, which typically sees price volatility tied to contract wins, earnings reports, guidance updates, or changes in industry sentiment. Without headline evidence, the rally could reflect several categories of catalyst: a delayed market reaction to company announcements or earnings from earlier in the week that haven't yet appeared in the RSS feed, short covering if the stock trades with high short interest, general sector rotation into industrial equities, or speculative technical strength. The rank as the 34th biggest gainer suggests this is notable but not extreme movement for the day, which is consistent with either a moderate positive development or accumulation-driven technical strength rather than a major news-driven shock.

CODX

Co-Diagnostics, Inc.Healthcare

$2.39+$0.42

+21.3%

NASDAQ · Mkt cap $6.9 M

Co-Diagnostics announced development of an Ebola diagnostic assay following a WHO emergency alert and simultaneously disclosed a $3 million private placement, both catalysts likely driving the 21% gain.

The stock's 21% jump appears grounded in two material events announced within 24 hours. First, the company disclosed it has completed development of a Bundibugyo virus Ebola assay and is prepared for rapid deployment if outbreak conditions warrant expanded diagnostic response. This positions Co-Diagnostics as a potential beneficiary of a global health emergency, which for a diagnostics company can translate to significant near-term revenue opportunities. Second, and equally notable, the company announced a $3 million private placement priced at-the-market under Nasdaq rules on May 20, which often signals management confidence and provides capital for operations or R&D acceleration. The combination of a timely public health opportunity and a concurrent capital raise appears to have catalyzed investor enthusiasm for a small-cap diagnostics play with demonstrated platform agility.

TATT

TAT Technologies Ltd.Industrials

$39.54+$6.85

+21.0%

NASDAQ · Mkt cap $520 M

TAT Technologies surged 21% after reporting Q1 results that beat earnings expectations by 40.54% and expanded backlog to ~$580 million, offsetting modest revenue miss due to supply chain delays.

The headlines present conflicting messages on the same day. One source states TAT "missed" earnings and revenue expectations, while multiple other sources confirm a +40.54% earnings surprise and +2.70% revenue surprise for Q1 2026. The company also announced a significant increase in backlog and long-term agreements to approximately $580 million, attributed to strong demand in aerospace and defense markets. Management acknowledged supply chain disruptions impacted near-term delivery timing but characterized underlying demand as robust. The 21% gain likely reflects investor focus on the substantial earnings beat, expanded order backlog, and positive forward demand signals rather than the modest near-term revenue headwind. The backlog expansion is particularly significant for an aerospace services provider, as it signals future revenue visibility and sustained customer demand despite operational near-term challenges.

IREG

Leverage Shares 2x Long IREN Daily ETF

$19.49+$3.34

+20.7%

NASDAQ

No news headlines are available for IREG in the last 48 hours, but the stock is a 2x leveraged ETF tracking IREN, so a ~10% gain in the underlying would mechanically produce this ~20% move.

Zero headlines appeared in the Yahoo Finance RSS feed for the last 48 hours, so there is no identifiable news catalyst. However, IREG is a leveraged daily ETF with 2x long exposure to IREN (Iren Energy, a renewable energy company). Leveraged ETFs amplify the daily returns of their underlying index or stock by their stated multiplier. A 10% move in IREN would mechanically translate to approximately a 20% move in IREG through leverage mechanics. The actual driver of IREN's 10% gain could stem from any number of causes—positive earnings or guidance, sector rotation, analyst upgrades, contract announcements, or broader clean energy sentiment—but none of those causes are documented in the available headlines. The lack of news does not rule out a legitimate catalyst; it simply means no major headline was captured or published to this particular feed within the 48-hour window.

XNDU

Xanadu Quantum Technologies Limited Class B Subordinate Voting SharesTechnology

$14.13+$2.41

+20.6%

NASDAQ · Mkt cap $3.4 B

Xanadu reported a 4x revenue climb in its first public-company quarter with progress on its photonic quantum roadmap and partner commercialization, driving strong investor confidence in the quantum computing narrative.

The headline announces Xanadu's first quarterly results as a public company, highlighting a fourfold increase in revenue alongside advancement in wafer iteration and partner-led commercialization efforts supporting the company's photonic quantum computing roadmap. This is a concrete operational milestone that validates the company's technical progress and commercial traction. For a quantum computing firm—a sector with high growth expectations but historically limited revenue—a 4x quarterly revenue increase with named partnership support constitutes the type of inflection point that can trigger momentum-based buying. The headline explicitly frames this as "Roadmap Gains Traction," which directly addresses investor skepticism about execution risk. The 20.56% single-day gain is large but not implausible for a small-cap growth stock responding to materially positive first-quarter results.

IRE

Daily Target 2X Long IREN ETF

$25.88+$4.35

+20.2%

AMEX

No news headlines were found in the last 48 hours, but IRE is a 2X leveraged long ETF tracking IREN, so a sharp move in the underlying stock would be amplified roughly double in this fund, making a 20% gain plausible from a 10% underlying rally.

No news was published in the 48-hour window preceding this move, so the immediate catalyst is not visible in the provided headlines. However, IRE's structure as a daily target 2X long leveraged ETF means it is designed to deliver twice the daily returns of its underlying asset IREN. A 10% move in IREN would typically produce approximately a 20% move in IRE, which is consistent with today's observed price action. The actual driver would lie in IREN itself—this could stem from company-specific news about IREN that has not yet surfaced in Yahoo Finance's RSS feed, a broader market rally affecting the underlying holding, or intraday volatility that created leverage-amplified gains. Without visibility into IREN-specific catalysts or market context, the precise cause remains unknown, though the magnitude is entirely consistent with how leveraged ETFs behave.

BDTX

Black Diamond Therapeutics, Inc.Healthcare

$3.60+$0.60

+20.0%

NASDAQ · Mkt cap $116 M

Black Diamond Therapeutics announced a May 21 webcast to discuss updated Phase 2 results for silevertinib in lung cancer, likely triggering optimism ahead of the data presentation and driving a 20% single-day gain.

The company disclosed on May 19 that it will host a webcast on May 21 to present updated results from a Phase 2 trial of silevertinib in first-line EGFR-mutant NSCLC. For a clinical-stage oncology company, positive or anticipated positive phase 2 data is a material catalyst that can move the stock sharply. The announcement itself does not contain the trial results, but the scheduling of an investor webcast to highlight these results suggests the company views them as worth presenting to investors. The timing (announcement on May 19, webcast on May 21) would ordinarily allow investors two days to react; the +20% move on May 20 reflects pre-event enthusiasm and positioning ahead of the actual data reveal. This is a classic pre-catalystmove for a clinical-stage biotech stock where trial progression is the primary value driver.

BZFD

BuzzFeed, Inc.Communication Services

$1.57+$0.26

+19.8%

NASDAQ · Mkt cap $93 M

No news headlines were found in the last 48 hours, so the 19.85% gain on BZFD is unexplained by publicly reported events; the move likely reflects technical trading, short-covering, or unindexed catalysts.

Despite a significant intraday jump that placed BZFD in the top 41 gainers for May 20, 2026, no news headlines were available via Yahoo Finance in the preceding 48 hours. This absence of reported catalysts makes direct causal attribution impossible. BuzzFeed is a small-cap, thinly traded media company with a history of volatility and significant short interest, making it susceptible to technical reversals, short-squeeze dynamics, or sentiment shifts that may not be immediately captured in mainstream financial news feeds. Another possibility is that a company-specific announcement or filing occurred but has not yet propagated through the RSS feed used here. Retail trading activity or algorithmic rebalancing could also explain an outsized one-day move in a low-priced stock with modest liquidity.

CRMU

Leverage Shares 2x Long CRML Daily ETF

$7.33+$1.21

+19.8%

NASDAQ

No news headlines were found in the last 48 hours, but CRMU is a 2x leveraged long ETF tracking CRML, so a ~10% move in the underlying would mechanically produce this ~20% gain in the leveraged product.

Zero news items appeared in the Yahoo Finance RSS feed for the past two days, so no specific catalyst (earnings, guidance, product news, regulatory action) can be identified from headlines. However, CRMU's structure as a 2x daily leverage ETF means its performance is mechanically linked to the underlying CRML security. A ~10% rally in CRML would automatically produce approximately a 20% gain in CRMU before fees. The 19.75% move is consistent with normal leveraged ETF mechanics. Without headlines about CRML itself, the cause of CRML's move remains unknown—it could stem from sector rotation, technical momentum, delayed news, insider activity, or other market dynamics affecting the underlying asset. The absence of news does not mean no catalyst occurred, only that it was not captured in the headline feed examined.

OTLK

Outlook Therapeutics, Inc.Healthcare

$0.27+$0.04

+19.5%

NASDAQ · Mkt cap $167 M

No news headlines were found in the last 48 hours to explain OTLK's 19.53% gain, so the move likely stems from technical trading, rumors, or a delayed market reaction to prior events not captured in this news feed.

Outlook Therapeutics is a small-cap biotech stock trading at $0.27, and the absence of any recent news headlines makes it impossible to pinpoint a specific catalyst from publicly reported information. The stock's low price and illiquid nature make it susceptible to technical bounces, short-covering, or speculative trading on minimal volume. Biotech stocks in this size category can also gap on delayed announcements, trial results, FDA correspondence, or broader sector sentiment shifts that may not immediately propagate through major news feeds. Without access to company filings, press releases, or sector-specific sources, reasonable hypotheses include a rebound from oversold technicals, accumulation by retail traders, or a development in pipeline programs that hasn't yet reached mainstream financial news.

ABVE

Above Food Ingredients Inc. Common StockConsumer Defensive

$0.55+$0.09

+19.3%

NASDAQ · Mkt cap $4.9 M

No news headlines were available in the last 48 hours for ABVE, so the 19.35% gain cannot be attributed to a disclosed catalyst; the move likely reflects technical trading, a delayed market reaction, or untracked social media activity.

The absence of any recent news in the Yahoo Finance RSS feed means we cannot point to an earnings announcement, FDA approval, partnership, or guidance change to explain the jump. ABVE is a small-cap stock in the food ingredients space, and such stocks can experience outsized moves on thin volume from retail interest, short covering, or technical breakouts that occur without accompanying press releases. It is also possible a catalyst broke on another news service or social platform ahead of traditional financial media coverage, or that the move reflects a delayed reaction to older news. Without access to trading volume, short interest data, or broader market context from that trading day, we cannot determine whether this was momentum-driven, squeeze-related, or fundamentally motivated.

SMCX

Daily Target 2X Long SMCI ETFFinancial Services

$15.93+$2.54

+19.0%

AGAE

Allied Gaming & Entertainment Inc.Technology

$0.50+$0.08

+18.9%

NASDAQ · Mkt cap $76 M

No news headlines were found in the last 48 hours, so the 18.87% gain cannot be attributed to a specific announced event. The move likely reflects either delayed reaction to prior news, technical trading, or market speculation on an illiquid micro-cap security.

Allied Gaming & Entertainment trades on NASDAQ at $0.50 per share and gained nearly 19% on a snapshot date of May 20, 2026, yet no financial news, earnings announcements, regulatory approvals, partnerships, or guidance updates appeared in the last two days. This disconnect between price action and headline coverage is common in micro-cap and penny stocks, which often trade on low volume and respond to factors outside traditional news feeds. Possible explanations include a delayed market reaction to earlier press releases not captured in the 48-hour window, momentum trading from a technical breakout, short covering, or investor speculation tied to gaming and entertainment sector tailwinds. Without corroborating headlines or structural insight into the stock's capital structure or float, attribution remains speculative.

PRHI

Presurance Holdings, Inc.Financial Services

$0.77+$0.12

+18.8%

NASDAQ · Mkt cap $25 M

No news headlines were found in the last 48 hours, so the 18.83% gain cannot be directly tied to a reported event. The move may reflect technical trading, delayed news pickup, or market sentiment shifts in the micro-cap healthcare space.

The absence of any recent news headlines makes it impossible to identify a specific catalyst for PRHI's strong single-day gain. Presurance Holdings is a small-cap healthcare company trading at $0.77, a price range typically associated with higher volatility and lower liquidity. Moves of this magnitude in stocks at this valuation tier are often driven by technical factors such as short-covering, options expiration effects, or algorithmic rebalancing rather than fundamental news. Alternatively, a material announcement may have occurred but not yet been indexed by Yahoo Finance's RSS feed, or the stock may have responded to sector-wide sentiment, insider activity, or mentions in retail trading forums that would not appear in formal headlines.

ALZN

Alzamend Neuro, Inc.Healthcare

$1.20+$0.19

+18.8%

NASDAQ · Mkt cap $7.4 M

No news headlines were found in the last 48 hours, so the 18.81% gain cannot be attributed to a specific announced event. The move is likely driven by technical factors, market sentiment, or information not captured in the RSS feed.

ALZN experienced a strong single-day gain of 18.81%, ranking it among the top gainers, yet no recent headlines are available to explain the move. This is not uncommon for smaller-cap biotech stocks like Alzamend Neuro, which can experience significant price swings on thin volume, technical breakouts, or sentiment shifts that may not immediately generate press coverage. Possible explanations include a delayed disclosure not yet picked up by the RSS feed, short-covering activity, positive commentary from an analyst or influential investor, clinical trial developments announced through channels other than traditional press releases, or simply a technical rebound after prior weakness. Without headline evidence, any specific cause remains speculative.

MREO

Mereo BioPharma Group plcHealthcare

$0.28+$0.04

+18.8%

AMIX

Autonomix Medical, Inc. Common StockHealthcare

$0.34+$0.05

+18.7%

NASDAQ · Mkt cap $5.7 M

Autonomix Medical received a U.S. patent grant on May 19 for its transvascular monitoring and treatment technology, strengthening its intellectual property position in neuromodulation and likely driving the 18.65% single-day gain.

The headline describes a patent award for minimally invasive transvascular access to nerve targets, which the company characterizes as strengthening its IP foundation for next-generation neuromodulation technology. For early-stage or clinical-stage medical device firms, patent grants often signal progress in their core technology platform and can reduce perceived IP risk for investors. The timing of the announcement on May 19 aligns tightly with the May 20 price jump, and the language emphasizing "real-time procedural validation" and "unlocks" suggests the company views this as a meaningful competitive moat. However, the headline does not specify clinical efficacy, regulatory pathway clarity, commercialization timeline, or revenue impact, so the move may reflect sentiment about IP strength rather than concrete business progress.

Biggest Losers

Wed, May 20, 2026 50

LICN

Lichen International LimitedIndustrials

$1.09−$1.74

-61.5%

NASDAQ · Mkt cap $21 M

LICN dropped 61.48% with no news headlines available in the last 48 hours, suggesting the catalyst was either an undetected announcement, technical break, or broader market event not yet reflected in financial news feeds.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to attribute this severe 61 percent decline to a specific announced event such as earnings disappointment, regulatory action, or management change. For a micro-cap NASDAQ stock trading at $1.09, several common causes warrant consideration: undisclosed insider selling or lockup expiration, a delayed press release not yet indexed by major news aggregators, a sharp technical breakdown below key support that triggered automated selling, or a broader sector rotation affecting similar small-cap securities. Micro-cap stocks are also more susceptible to rumor-driven moves and liquidity events that may not generate immediate mainstream news coverage. Without substantive headlines or known structural catalysts, the true driver remains unclear.

SOPA

Society Pass IncorporatedCommunication Services

$0.08−$0.10

-55.6%

NASDAQ · Mkt cap $7.7 K

No news headlines were found in the last 48 hours, so the 55.56% drop cannot be directly attributed to a named catalyst. The decline is likely driven by technical selling, market sentiment, or a delayed announcement not yet captured in RSS feeds.

Society Pass Incorporated experienced a severe single-day decline with no corresponding news coverage in the last 48 hours according to the provided RSS data. This disconnect between magnitude of move and headline absence is notable. For a microcap stock trading at $0.08, causes of such sharp drops typically include liquidation pressure from institutional holders, short accumulation ahead of negative catalysts, delayed disclosure of poor earnings or operational setbacks, or technical breakdown below key support levels. Without access to news sources outside the 48-hour window or intra-day developments, pinpointing the exact cause is not possible. The stock's low price point and penny-stock classification make it vulnerable to momentum-driven selling and liquidity constraints that can amplify declines.

JYD

Jayud Global Logistics LimitedIndustrials

$0.90−$0.98

-52.1%

NASDAQ · Mkt cap $8.5 M

No news headlines were available in the last 48 hours to explain the severe 52% single-day drop in JYD, leaving the cause unknown but suggesting either a delayed market reaction to an untracked announcement, a technical catalyst, or broader sector pressure in logistics stocks.

The complete absence of recent news headlines makes it impossible to attribute this 52% decline to a specific corporate event such as earnings disappointment, guidance cut, regulatory action, or contract loss. JYD is a small-cap logistics company trading at $0.90, and stocks at this price level and market capitalization are often subject to pronounced swings driven by low liquidity, retail trading activity, or delayed dissemination of material information that may not appear immediately in major RSS feeds. The magnitude of the loss ranks it among the day's three biggest losers, suggesting a genuine material catalyst rather than random noise. Plausible but unconfirmed categories include: (1) an untracked press release or earnings announcement released before market open or on a company channel not captured by Yahoo Finance within the 48-hour window, or (2) sector-wide pressure if logistics or transportation stocks faced a broad selloff. Without access to the company's investor relations page or real-time news alerts, the true cause remains speculative.

YMT

Yimutian Inc. American Depositary SharesTechnology

$1.12−$0.89

-44.3%

NASDAQ · Mkt cap $2.3 M

Yimutian Inc. received a Nasdaq delisting notice due to failure to meet minimum market value requirements for listed securities, triggering a 44% single-day collapse as investors fled the stock ahead of a potential exchange removal.

The company announced on May 19 that it received written notifications from Nasdaq regarding its failure to maintain the required minimum market value of listed securities. This is a critical regulatory event that directly threatens the company's continued exchange listing. The headline indicates the notification was received and that a hearing request process is available, but delisting proceedings represent an existential threat to equity valuations as removal from major exchanges typically results in liquidity collapse, institutional investor forced sales, and sharply reduced trading volumes. The 44% single-day drop reflects the market repricing YMT shares given heightened delisting risk. The stock's fourth-place ranking among daily losers confirms this was a coordinated institutional response to known news rather than a technical glitch or delayed disclosure.

HLP

Hongli Group Inc.Basic Materials

$0.55−$0.40

-41.8%

NASDAQ · Mkt cap $90 M

No news headlines were found in the last 48 hours to explain HLP's 41.81% decline, suggesting the move may be driven by technical selling, delayed announcements, or market-specific factors unrelated to recent public information.

The absence of any Yahoo Finance headlines in the prior 48 hours is notable given the severity of the move, ranking HLP as the fifth-biggest loser of the day. This disconnect between magnitude and publicly available news suggests either that the catalyst was announced before the 48-hour window, that the stock is experiencing technical selling pressure or liquidity-driven volatility common to low-priced equities, or that a material event occurred but has not yet been covered by major financial news feeds. Penny stocks and micro-cap securities are particularly susceptible to sharp moves from rumors, insider transactions, or execution-driven selling without corresponding press coverage. Without substantive evidence, the most likely categories of cause are technical capitulation, delayed earnings or regulatory news, or shifts in sentiment that have not yet crystallized into formal announcements.

RUBI

Rubico Inc.Industrials

$0.81−$0.56

-41.1%

NASDAQ · Mkt cap $3.2 M

Rubico announced a $5.0 million public offering on May 20, which likely triggered dilution concerns and prompted the 41% single-day sell-off typical of equity offerings in small-cap shipping stocks.

The news headline confirms that Rubico announced the pricing of a $5.0 million public offering on the same day as the sharp decline. Public offerings, particularly at small valuations relative to market cap, are commonly viewed negatively by existing shareholders due to immediate dilution of ownership and earnings per share. The incomplete headline text prevents full assessment of offer terms such as share price, discount, or use of proceeds, but equity raises of this size at a micro-cap price point ($0.81) typically signal either capital stress or valuation weakness that the market penalizes swiftly. The stock's rank as the sixth biggest loser suggests the offering news was the dominant driver of sentiment, though secondary factors like broader shipping sector weakness cannot be ruled out from the data provided.

AIM

AIM ImmunoTech Inc.Healthcare

$0.25−$0.16

-38.4%

AMEX · Mkt cap $7.3 M

AIM ImmunoTech announced a $2.4 million financing deal on May 20 that likely triggered the 38% drop due to shareholder dilution concerns common in small-cap biotech direct offerings.

The company disclosed a registered direct offering and private placement totaling $2.4 million on the same day as the sharp decline. In small-cap biotechs, direct offerings and concurrent private placements typically signal dilution to existing shareholders and often indicate financial stress or the need for immediate capital. The May 19 announcement about increased stockholder equity and a promissory note extension through June 2027 suggests the company was managing debt pressures, which the follow-up financing announcement on May 20 reinforces. The timing and structure of raising capital through direct offerings rather than traditional means is generally interpreted negatively by markets as a sign of limited financing alternatives. For a micro-cap stock trading at $0.25, the magnitude of dilution from a $2.4 million raise can be substantial relative to existing equity value.

JUNS

Jupiter Neurosciences, Inc.Healthcare

$0.21−$0.12

-35.9%

NASDAQ · Mkt cap $3.7 M

Jupiter Neurosciences announced a $100 million licensing deal for an MDMA therapeutic and a $2 million registered direct offering on the same day, likely causing shareholder dilution concerns to outweigh the positive asset acquisition news.

On May 20, Jupiter announced two major developments: a $100 million term sheet to license exclusive U.S. rights to PharmAla's ALA-002 MDMA therapeutic, and a $2 million registered direct offering. The licensing deal is genuinely positive—it positions JUNS as a player in next-generation MDMA therapeutics following Trump's April 2026 executive order accelerating psychedelic medicine. However, the 35.94% single-day drop suggests the market weighted the dilutive impact of the registered direct offering more heavily than the asset acquisition. For a micro-cap biopharmaceutical stock trading at $0.21, new equity issuance signals cash pressure and typically triggers immediate sell-offs regardless of concurrent strategic wins. The timing of both announcements on the same day may have compounded negative sentiment as investors digested dilution risk faster than upside optionality.

AMSS

AMASS Brands Inc. Common StockConsumer Defensive

$11.35−$5.65

-33.2%

NASDAQ · Mkt cap $11 M

AMASS Brands completed its Nasdaq direct listing today under ticker AMSS, and the stock fell 33.24% on its first day of trading, suggesting demand was substantially weaker than the IPO valuation or offering price.

The company announced completion of a Nasdaq direct listing on May 20, 2026, the same day as the recorded price snapshot. A direct listing allows existing shareholders to sell shares on the public market without a traditional underwritten IPO process. The 33% single-day decline on debut indicates that either the opening price was set above market equilibrium, investor demand fell short of supply, or both. The headline provides no detail on the offer price, valuation, or trading context that would clarify whether this was a modest repricing or a significant disappointment. Direct listings can experience volatile first-day moves depending on lockup structures, available float, and retail participation. Without the offering or reference price, we cannot determine if this was an expected cool-down or a signal of poor investor reception to AMASS's business model as a multi-category beverage platform.

JEM

707 Cayman Holdings Limited Ordinary SharesConsumer Cyclical

$1.38−$0.60

-30.3%

NASDAQ · Mkt cap $2.8 M

No news headlines were found in the last 48 hours, so the 30% drop cannot be attributed to a reported event; the cause likely involves technical selling, a delayed announcement, or market-specific factors affecting this small-cap Cayman Islands shell company.

JEM experienced a severe single-day drop of 30% with zero news coverage in the prior 48 hours according to the provided feed. This absence of headlines is significant because a move of this magnitude typically correlates with a major corporate action or earnings event. For a low-liquidity, micro-cap Cayman Islands holding company, possible explanations include a regulatory filing or delisting risk announcement made outside the Yahoo Finance RSS feed window, insider selling or lock-up expiration, technical breakdown below support levels, or a negative rumor circulating on social media or message boards that drove algorithmic or retail selling. Without corroborating news, we cannot confirm which of these categories applies.

YYGH

YY Group Holding LimitedIndustrials

$0.60−$0.21

-25.8%

NASDAQ · Mkt cap $4.5 M

YY Group announced the launch of OpenClaw agentic AI deployment across Southeast Asian hotel clients on the same day it fell 25.81%, suggesting the market was disappointed by the announcement or its strategic implications despite management's growth optimism.

The company released news of a major product rollout (OpenClaw) and highlighted potential operating leverage and margin expansion as deployments scale. This is ostensibly positive strategic news. However, the stock fell sharply on the announcement date itself, indicating the market either (1) viewed the deployment scope or revenue potential as underwhelming relative to expectations, (2) had already priced in this initiative and sold on the news, (3) raised concerns about execution risk or capital requirements for scaling, or (4) the announcement triggered a broader rotation out of the stock for reasons unrelated to the content itself. Without information on investor guidance, analyst reactions, or broader market context for AI software stocks on this date, the precise cause remains unclear. The magnitude of the decline (ranked 11th biggest loser) suggests material negative sentiment, not a mild disappointment.

WGRX

Wellgistics Health, Inc.Healthcare

$0.13−$0.04

-23.2%

NASDAQ · Mkt cap $157 M

Wellgistics announced a reverse stock split on May 20, which typically signals financial distress and dilution concerns; this likely triggered the 23% single-day drop despite concurrent news of a partnership and improving quarterly pharmacy revenue.

The reverse stock split announcement is the most concrete negative catalyst in the headlines. Reverse splits are commonly used by companies trading below $1 per share to regain exchange compliance, and they are generally perceived as a bearish signal by the market because they indicate financial weakness without improving underlying fundamentals. The stock's current price of $0.13 suggests it was already in distressed territory. While the May 20 announcements also included a binding term sheet for a new joint venture called DelivMeds AI with Datavault AI and evidence of improving pharmacy revenue (from $0.1 million in November 2025 to $0.6 million in April 2026), these positive developments appear to have been overwhelmed by the negative sentiment surrounding the reverse split. The timing of all three announcements on the same day may indicate the company was attempting damage control, but the split announcement likely dominated investor perception.

LZMH

LZ Technology Holdings Limited Class B Ordinary SharesTechnology

$0.06−$0.02

-22.9%

NASDAQ · Mkt cap $11 M

LZ Technology announced a 1-for-20 reverse share split approved by shareholders and board on May 20, 2026, which typically triggers negative sentiment as investors perceive it as a sign of financial distress or delisting risk.

The company announced a reverse stock split on the same day as the -22.93% decline. Reverse splits are mechanically neutral to shareholder value but are widely viewed as bearish signals by the market because they are often undertaken by struggling companies to maintain exchange listing standards, improve optics, or indicate management distress. At $0.06 post-announcement, the stock was already trading at penny-stock levels, suggesting prior weakness. While the reverse split itself does not change underlying business fundamentals, investor psychology and forced selling by holders who view the action as a red flag commonly drive sharp declines on announcement day. The magnitude of the drop is consistent with typical reverse-split reactions in microcap equities.

AEHL

Antelope Enterprise Holdings LimitedIndustrials

$2.91−$0.83

-22.2%

NASDAQ · Mkt cap $6.5 M

No news headlines were available in the last 48 hours for AEHL, so the 22% decline cannot be attributed to a specific announced event. The drop likely reflects either a delayed market reaction to earlier news, technical selling, or untracked market gossip.

The absence of recent headlines in Yahoo Finance RSS for such a dramatic single-day loss is notable and limits direct causal analysis. AEHL is a small-cap stock trading at $2.91, which typically makes it more susceptible to volatility from low liquidity and retail trader activity. Possible drivers in the absence of news include: first, a delayed market reaction to negative developments announced more than 48 hours prior that have now propagated through the market; second, technical selling triggered by a broken support level or short-term chart breakdown; third, company-specific rumors or insider activity not yet reflected in official news feeds; or fourth, sector-wide selling pressure affecting small-cap Chinese or enterprise holdings stocks broadly. Without confirmed headlines, all explanations remain speculative.

WOK

WORK Medical Technology Group Ltd.Healthcare

$0.19−$0.05

-19.6%

NASDAQ · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 19.57% decline cannot be directly attributed to a specific disclosed event. The move likely reflects either technical selling, market sentiment, or undisclosed developments in a micro-cap stock.

The absence of recent news makes direct attribution impossible. WORK Medical Technology Group is a micro-cap stock trading at $0.19, which typically exhibits high volatility and thin liquidity. Stocks in this price range are prone to sharp moves driven by technical factors, retail trading activity, or news that may circulate outside major financial wires before appearing in formal reporting. Possible catalysts include delayed earnings announcements, clinical trial results, regulatory filings, or broad sector rotation away from small-cap healthcare names. Without headline evidence, determining the specific cause requires additional information beyond what Yahoo Finance has indexed.

SMCZ

Daily Target 2X Short SMCI ETF

$13.10−$2.97

-18.5%

NASDAQ

No news headlines were found in the last 48 hours, but SMCZ is a 2X inverse leveraged ETF tracking Super Micro Computer (SMCI), so a sharp decline in SMCZ almost certainly reflects a sharp rally in SMCI stock itself.

SMCZ is a daily target 2X short ETF, meaning it is designed to move in the opposite direction of SMCI at approximately two times the daily return magnitude. An 18.48% drop in SMCZ therefore implies that SMCI rallied roughly 9% or more on the day. Without headlines provided, we cannot identify the specific catalyst for SMCI's move. However, stocks in the semiconductor and server infrastructure space are highly sensitive to AI demand narratives, earnings surprises, guidance revisions, large customer wins or losses, supply chain developments, and macroeconomic sentiment shifts. The absence of news in the provided feed does not mean no news occurred; it may simply reflect gaps in the RSS source or a delay in headline indexing. A 9% single-day rally in a mega-cap semiconductor stock typically reflects material news, though the details are not available here.

RVSN

Rail Vision Ltd.Industrials

$4.97−$1.10

-18.1%

NASDAQ · Mkt cap $11 M

Rail Vision announced a quantum computing integration with Google's error correction dataset on the day of an 18% drop, but the announcement itself does not explain the decline; the sell-off likely reflects profit-taking, market skepticism about quantum claims, or unrelated sector headwinds.

The only headline provided is a press release from Rail Vision announcing that Quantum Transportation has integrated Google's public surface-code dataset into a quantum error correction transformer. This is a positive-sounding technical development, not a negative catalyst that would trigger an 18% decline. The announcement came at 11:32 UTC on the same day as the drop, making timing coincidental rather than causal. The disconnect suggests the sell-off was driven by something other than this news: either profit-taking in a volatile microcap, market skepticism about quantum technology claims, a broader market or transportation sector decline, or an undisclosed negative event not captured in the 48-hour news window. Rail Vision is an early-stage technology company with a history of speculative valuations, making it vulnerable to sentiment shifts independent of individual press releases.

NXXT

NextNRG Inc.Utilities

$0.67−$0.15

-17.9%

NASDAQ · Mkt cap $40 M

NextNRG posted record 195% revenue growth and April's best monthly revenue on record, but the earnings call revealed severe liquidity challenges and net losses, triggering a sharp selloff as growth concerns clash with financial sustainability questions.

The headline evidence presents a mixed picture typical of high-growth companies burning cash. On the positive side, NextNRG reported 56% year-over-year April revenue growth and 195% overall Q1 revenue increase, marking historical highs. However, the earnings call summary explicitly flags liquidity and net loss hurdles as the company expands its energy infrastructure pipeline. This suggests investors parsed the call and concluded that while top-line growth is impressive, the company's inability to achieve profitability and its cash position constraints outweigh near-term revenue momentum. The stock's ranking as the 18th biggest loser indicates this was a meaningful repricing. The sharp 17.95% single-day drop likely reflects disappointment that record growth is not translating to financial health, a classic bear case for unprofitable growth stocks.

GDC

GD Culture Group LimitedCommunication Services

$0.12−$0.02

-17.4%

NASDAQ · Mkt cap $7.8 M

GDC fell 17.44% with no news headlines in the last 48 hours, making the specific catalyst unclear and likely attributable to technical selling, market sentiment shifts, or undisclosed company developments.

No recent news headlines are available to explain GDC's sharp 17.44% decline on May 20, 2026. Without identified catalysts such as earnings misses, insider selling, regulatory actions, or strategic announcements, the move falls into a category of potential causes that spans technical factors like stop-loss cascades or momentum reversals, broad market weakness affecting small-cap or speculative stocks, loss of investor confidence unacknowledged in major headlines, or delayed disclosure of material news not yet captured by the RSS feed. Stocks trading at penny-stock levels like $0.12 are often more volatile and subject to lower liquidity and information efficiency, which can amplify moves on modest volume shifts.

IONZ

Daily Target 2X Short IONQ ETF

$3.84−$0.78

-16.9%

NASDAQ

No news headlines were found in the last 48 hours, but IONZ is a 2X short ETF on IonQ, so a 16.88% drop likely reflects a sharp rally in the underlying IONQ stock that the inverse position amplifies downward.

No recent news headlines are available to explain this move directly. However, IONZ is a leveraged inverse (short) ETF targeting IonQ, meaning it moves in the opposite direction of IONQ with 2X daily amplification. A 16.88% decline in IONZ most likely corresponds to a significant single-day gain in IonQ stock itself, which the 2X short multiplier magnifies into a larger loss for inverse holders. The catalyst for IonQ's rally is not evident from the provided headlines, but could involve positive quantum computing developments, analyst upgrades, sector enthusiasm, or general equity market strength. Without access to IONQ-specific news or market data, the true driver of IonQ's move—and therefore IONZ's decline—remains unknown.

GOCO

GoHealth, Inc.Financial Services

$0.63−$0.12

-16.5%

NASDAQ · Mkt cap $9.9 M

No news headlines were found in the last 48 hours, so the 16.5% drop cannot be tied to a specific announced catalyst. The decline likely reflects either delayed reaction to older news, technical selling, sector weakness, or an unannounced development.

GoHealth is an online health insurance marketplace. Without recent news coverage, the sharp one-day loss cannot be attributed to a named event such as earnings, guidance revision, regulatory action, or partnership announcement. For this type of consumer-facing digital platform stock, typical catalysts for declines include deteriorating user metrics, competitive pressure, changes in insurance carrier partnerships, regulatory shifts affecting health insurance distribution, or macroeconomic headwinds affecting consumer spending. It is also possible that the move reflects accumulated sentiment from older news not captured in the last 48-hour window, technical breakdown below a key level, or sector-wide pressure on health or fintech stocks on that specific trading day.

SBFM

Sunshine Biopharma, Inc.Healthcare

$0.37−$0.07

-16.5%

NASDAQ · Mkt cap $4.5 M

Sunshine Biopharma announced closure of an $18 million public offering on May 19, which likely triggered the 16.52% drop due to dilution concerns from new share issuance and warrant exercises.

The company announced completion of a public offering consisting of $6 million upfront with up to $12 million additional in potential proceeds from warrant exercises. In biotech and small-cap stocks, announced dilutive capital raises typically depress share price immediately as existing shareholders face ownership dilution and potential downward pressure from new warrant holders exercising their positions. The timing of the announcement on May 19 and the stock's ranking as the 22nd biggest loser on May 20 aligns logically with this event. However, the headline provided is incomplete and does not specify pricing, number of shares issued, warrant strike prices, or any accompanying narrative that might contextualize whether investors viewed this as favorable or unfavorable beyond the mechanical dilution effect. Without those details, the inference relies on typical market behavior to large equity raises in this sector and market cap range.

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$4.46−$0.86

-16.2%

NASDAQ · Mkt cap $6.9 M

SUGP fell 16% despite reporting a major Hong Kong government contract win that initially boosted the stock 20%, suggesting a sharp reversal or sell-the-news event later the same trading day.

The headlines report that SU Group Holdings won a new contract from the Hong Kong Civil Aviation Department, which triggered a 20% intraday surge on Wednesday. However, the stock closed down 16.17% on the same day, making it the 23rd biggest loser on NASDAQ. This dramatic reversal from +20% to -16% within a single session is consistent with a sell-the-news dynamic, where initial enthusiasm fades as investors reassess valuation, contract terms, or broader market conditions. Alternatively, negative information unrelated to the contract announcement—such as guidance concerns, insider selling, or sector headwinds—may have emerged after the contract news. Without access to intraday timing, full contract details, or subsequent statements, the exact trigger for the reversal remains unclear, but the pattern strongly suggests profit-taking or new negative information overwhelmed the positive contract narrative.

PERI

Perion Network Ltd.Communication Services

$9.01−$1.66

-15.6%

NASDAQ · Mkt cap $404 M

Perion reported Q1 2026 results that beat earnings expectations but missed on revenue growth, and despite reaffirmed full-year guidance, the market focused on the company's continued struggle to accelerate top-line growth, triggering the 15.56% sell-off.

The headlines reveal a mixed earnings picture released on May 20, 2026. Perion exceeded earnings estimates by 83.33% but missed revenue expectations, with Q1 showing only modest revenue growth. Management reaffirmed full-year guidance and highlighted progress on new platforms (Perion One and Outmax AI agent) as the company transitions away from legacy web business. However, multiple headlines explicitly state the stock fell because Perion "continued to struggle to grow" and investors appear to have prioritized the revenue miss and sluggish top-line trajectory over the earnings beat and positive forward outlook. The disconnect between earnings strength and revenue weakness, combined with the market's apparent skepticism about growth acceleration despite management's optimism, likely drove the sharp decline as investors repriced expectations for near-term revenue momentum.

GAUZ

Gauzy Ltd. Ordinary SharesTechnology

$0.66−$0.12

-15.4%

NASDAQ · Mkt cap $6.9 M

No news headlines were found in the last 48 hours, so the 15.35% decline cannot be attributed to a specific company announcement; the drop likely reflects broader market weakness, technical selling, or an undetected news event.

With zero headlines in the provided news feed over the past 48 hours, there is no documented catalyst for Gauzy's sharp decline. Gauzy is a small-cap Israeli company focused on smart glass and dynamic glazing technology, a speculative sector where stocks can move sharply on sentiment shifts, technical breaks, or rumors not captured in mainstream feeds. Possible categories of cause include sector-wide weakness in specialty materials or clean tech, profit-taking after a recent rally, short-seller activity targeting micro-caps, or news that emerged outside the Yahoo Finance RSS window. Without headline evidence or knowledge of the company's recent trading pattern, we cannot determine whether this reflects company-specific deterioration or broader market dynamics.

PPBT

Purple Biotech Ltd.Healthcare

$2.98−$0.53

-15.1%

NASDAQ · Mkt cap $2.5 M

No news headlines appeared in the last 48 hours, so the 15% drop cannot be attributed to a disclosed catalyst. The decline likely stems from broader biotech sector weakness, technical selling, or an unannounced development.

Purple Biotech is a small-cap biotech stock, and the absence of recent news headlines in the provided data makes it impossible to tie the 15.10% drop to a specific disclosed event like clinical trial results, regulatory action, financing news, or guidance. Biotech stocks of this size are often sensitive to sector rotation, liquidity constraints, and technical momentum shifts independent of company-specific news. The stock could have been hit by broader weakness in micro-cap biotech indices, short-term trader liquidation, or a development that has not yet been widely reported on Yahoo Finance's RSS feed. Without additional context on the company's pipeline stage, cash position, or recent investor communications, any explanation remains speculative.

RXT

Rackspace Technology, Inc.Technology

$4.00−$0.70

-14.8%

NASDAQ · Mkt cap $839 M

RXT dropped 14.80% despite a positive hedge fund mention and analyst upgrade from BMO Capital on May 12, suggesting the decline reflects profit-taking after the stock's extraordinary 337.59% one-month surge rather than new negative news.

The only headline provided is a May 19 article highlighting RXT as one of the eight best rising tech stocks according to hedge funds, coupled with a reference to BMO Capital raising its price target on May 12. Both pieces are positive catalysts. However, the stock has experienced an explosive 337.59% gain over the past month, which creates significant downside risk from profit-taking and mean reversion. The sharp single-day drop of 14.80% occurring after such an extreme run-up is consistent with momentum exhaustion or investors locking in gains rather than a response to newly bearish fundamental news. No earnings misses, guidance cuts, contract losses, or other negative events are mentioned in the provided headlines. The timing of the decline immediately after the positive publicity could reflect that the move had already been priced in or that extreme momentum stocks tend to correct sharply after parabolic advances.

GCTK

GlucoTrack, Inc.Healthcare

$0.47−$0.08

-14.7%

NASDAQ · Mkt cap $3.7 M

No news headlines appeared in the last 48 hours, so the 14.67% drop cannot be attributed to any disclosed event; the cause remains unknown without additional information.

GlucoTrack (GCTK) lost nearly 15% on May 20, 2026, but no news was published in the 48-hour window preceding the move. Without headlines or disclosed corporate events, several categories of catalyst are possible: a delayed or after-hours announcement from earlier dates not yet indexed, technical selling triggered by price or volume levels, sector-wide pressure in medical devices or diagnostics, short-seller activity or negative social media, or an internal development (clinical setback, regulatory issue, financing need) not yet publicly announced. For a micro-cap medical device stock trading at $0.47, illiquidity and thin float can amplify intraday moves on modest trading volume. Without concrete news or structural characteristics specific to GCTK to analyze, attribution remains speculative.

HCAI

Hauchen AI Parking Management Technology Holding Co., Ltd.Industrials

$9.02−$1.53

-14.5%

NASDAQ · Mkt cap $7.9 M

No news headlines were published in the last 48 hours explaining HCAI's 14.50% decline, so the cause cannot be determined from available reporting.

The absence of recent news makes it impossible to identify a specific catalyst for HCAI's sharp 14.50% drop on May 20, 2026. For a small-cap NASDAQ-listed technology stock focused on parking management, typical triggers for such moves include quarterly earnings misses or guidance cuts, disappointing contract announcements, insider selling or dilution events, shifts in sector sentiment affecting parking-tech valuations, or technical selling following a break of support levels. A company in this space could also be affected by broader market corrections, changes in commercial real estate sentiment, or company-specific operational challenges that haven't yet been formally disclosed. Without headline confirmation, these remain speculative categories rather than established causes.

TDTH

Trident Digital Tech Holdings LtdTechnology

$1.49−$0.25

-14.4%

NASDAQ · Mkt cap $2.3 B

TDTH fell 14.37% on May 20th despite announcing a five-pillar strategy expansion into cybersecurity, AI, and agritech the prior day; the market reaction suggests investor skepticism about execution or valuation rather than support for the strategic pivot.

On May 19th, Trident Digital Tech unveiled an ambitious five-pillar strategy expanding from digital identity into cybersecurity, AI-driven infrastructure, government technology, digital commerce, and agritech across Africa and Asia-Pacific. This is a material strategic announcement that typically would attract investor attention. However, the stock dropped sharply the following day, ranking among the day's thirty biggest losers. The disconnect between the announcement and the price action suggests the market may be skeptical about the company's ability to execute across these new verticals, concerned about dilution risk from the required capital deployment, or viewing the diversification as a sign of weakness in the core business. Alternatively, the announcement may have been overshadowed by broader ADR weakness on May 20th, though the headline notes ADRs were tracking higher that morning. Without details on the company's financial position, cash runway, or analyst commentary on the strategy, it is difficult to pinpoint whether the sell-off reflects specific execution risk or general lack of investor confidence in management's ability to scale across emerging markets.

Jianzhi Education Technology Group Company LimitedTechnology

$0.76−$0.13

-14.3%

NASDAQ · Mkt cap $4.1 M

No news headlines were found in the last 48 hours, so the 14.25% drop on JZ cannot be directly attributed to a reported event. The decline likely reflects technical selling, sector rotation, or delayed market reaction to an earlier development not captured in this news feed.

The absence of news in the 48-hour window makes it impossible to pinpoint a specific catalyst for JZ's sharp decline. For a small-cap education technology stock trading at $0.76, typical drivers of such moves include sector headwinds affecting edtech names, shifts in investor sentiment toward Chinese equities or companies with regulatory exposure, options-related technical selling, or delayed market absorption of earlier announcements. The company operates in the regulated education sector in China, where policy risk and enrollment trends are structural considerations. Without current headlines, we cannot distinguish between idiosyncratic factors and broader market dynamics.

TMDE

TMD Energy LimitedEnergy

$0.70−$0.12

-14.2%

AMEX · Mkt cap $18 M

No news headlines were available in the last 48 hours for TMDE, so the 14.24% drop likely reflects either a delayed reaction to an earlier announcement, broad market weakness in the energy sector, or technical selling pressure.

The absence of recent news headlines makes it impossible to point to a specific catalyst for the drop. TMD Energy is a micro-cap energy stock trading at $0.70, a price point where liquidity is thin and daily swings can be volatile and driven by minimal news or technical factors. For a stock in this category, causes typically fall into a few categories: delayed market reaction to earnings or guidance released before the 48-hour window, sector-wide pressure on energy stocks, insider activity, analyst downgrades or coverage decisions that may not appear immediately in RSS feeds, or simple technical selling off resistance levels. Without access to company filings, insider transactions, or broader market context from the snapshot date, we cannot distinguish between these possibilities with confidence.

NIVF

NewGenIvf Group LimitedHealthcare

$0.74−$0.12

-14.2%

NASDAQ · Mkt cap $3.5 M

No news headlines were found in the last 48 hours for NIVF, so the 14.17% drop cannot be attributed to a specific announced event. The decline likely reflects either technical selling pressure, sector headwinds in fertility/biotech, or undisclosed market rumors.

The absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for NIVF's sharp 14.17% decline on May 20, 2026. NewGenIvf Group Limited is a small-cap fertility services company trading at $0.74, and stocks in this category are often prone to high volatility driven by multiple factors. Possible explanations include sector-wide selling pressure affecting fertility treatment providers, a delayed earnings announcement or guidance revision not yet reflected in the RSS feed, insider trading activity, short positioning unwinding, or broader market correlation to biotech indices. Without access to intraday trading data, analyst downgrades, or confirmed company statements, any specific attribution would be speculative rather than evidence-based.

SOXS

Direxion Daily Semiconductor Bear 3X ETF

$8.54−$1.39

-14.0%

AMEX

No news headlines were found in the last 48 hours, but SOXS is a 3X inverse leveraged semiconductor ETF, so a 14% drop most likely reflects a sharp rally in the underlying semiconductor index that day.

SOXS is a bearish leveraged ETF designed to move negative 3X relative to the Semiconductor Select Sector Index daily. A 14% decline in SOXS therefore suggests the semiconductor sector rallied approximately 4.7% on May 20th, 2026. Without news headlines in the search results, the cause of that rally cannot be pinned to a specific event, but semiconductor stocks typically respond to broad market risk-on sentiment, rate expectations, AI demand narratives, earnings surprises from major chip makers, or positive guidance. The absence of news in the Yahoo Finance RSS feed may reflect a gap in coverage rather than absence of a catalyst; institutional data sources or company-specific announcements may have driven the rally even if not captured in this feed.

INBS

Intelligent Bio Solutions Inc.Healthcare

$2.83−$0.46

-14.0%

NASDAQ · Mkt cap $8.1 M

No news headlines were found in the last 48 hours to explain the 13.98% drop, so the cause remains unclear; possible drivers include technical selling, sector headwinds, or unannounced company developments.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for INBS's sharp 14% decline. Intelligent Bio Solutions is a small-cap biotech/diagnostics company, and such stocks are sensitive to multiple invisible forces: technical momentum reversals, sector-wide biotech weakness, short covering or squeeze unwinding, delayed earnings misses or guidance reductions not yet widely reported, loss of institutional support, or undisclosed clinical or regulatory setbacks. Without access to real-time market commentary, social media chatter, insider trading alerts, or same-day press releases, the true driver cannot be determined from the data provided. The stock's ranking as the 35th biggest loser suggests this was a meaningful repricing, but the mechanism remains speculative.

VSTD

Vestand Inc.Consumer Cyclical

$0.48−$0.08

-13.9%

NASDAQ · Mkt cap $15 K

No news headlines were published in the last 48 hours for VSTD, so the 13.91% drop cannot be attributed to a specific announced event; the decline likely reflects technical selling, sector rotation, or undisclosed market-moving developments.

The absence of recent headlines makes it impossible to pinpoint a concrete catalyst for VSTD's sharp 13.91% decline. Given the stock's extremely low price of $0.48, it is likely a micro-cap or penny stock where volatility is typically high and liquidity thin, creating conditions where modest volume shifts or broader sector headwinds can generate outsized percentage moves. Possible drivers in this segment include technical breakdown below support levels, margin calls forcing liquidation, reduced retail interest, or delayed announcements not yet reflected in the RSS feed. Without public news tying to the move, any explanation remains speculative.

JETD

MAX Airlines -3X Inverse Leveraged ETNs

$3.83−$0.61

-13.7%

AMEX

No news was published in the last 48 hours, but JETD is a -3X inverse leveraged ETN on MAX Airlines, so a 13.74% drop likely reflects a sharp rally in MAX Airlines stock, which would naturally trigger a steep decline in an inverse product.

The absence of any recent headlines means we cannot point to a company-specific catalyst for JETD's 13.74% loss. However, JETD's structure is critical context here. As a -3X inverse leveraged ETN, it is designed to move opposite to MAX Airlines' performance, amplified threefold. If MAX Airlines rose sharply today or yesterday, JETD would fall proportionally. A roughly 4.6% gain in MAX Airlines would produce approximately this magnitude of loss in the inverse product, accounting for leverage decay and daily rebalancing effects. Without data on MAX Airlines' price action, we cannot confirm this is the cause, but it remains the most mechanically probable explanation for an inverse leveraged product's large single-day decline.

SAGT

SAGTEC GLOBAL LtdTechnology

$0.89−$0.14

-13.3%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 13.26% decline cannot be directly attributed to a specific announced event; the drop likely reflects technical selling, market-wide pressure, or undisclosed company developments.

The absence of any recent news headlines makes it impossible to pinpoint a concrete catalyst for SAGT's decline. Given that the stock trades on NASDAQ and has experienced a sharp single-day loss placing it among the top 38 losers, the move could stem from several sources. Micro-cap and small-cap stocks like SAGT are often more volatile and responsive to technical factors such as options expiration, short covering reversals, or algorithmic selling triggered by price levels. Alternatively, a material announcement such as a secondary offering, insider sales, regulatory warning, or earnings miss may have occurred but not yet propagated to the RSS feed monitored. Without access to company filings, SEC alerts, or real-time news wires, we cannot rule out delayed disclosure of negative developments. The lack of headline coverage itself is noteworthy for a stock experiencing a top-40 daily loss.

LABT

Lakewood-Amedex Biotherapeutics Inc. Common StockHealthcare

$0.75−$0.11

-13.1%

NASDAQ · Mkt cap $3.8 M

No news headlines were found in the last 48 hours, so the 13.11% drop cannot be directly attributed to a specific announced event. Biotech microcaps like LABT often experience sharp moves on low volume driven by technical selling, margin calls, or unreported developments.

The absence of any headline coverage in the past 48 hours means there is no news-driven explanation available from the provided sources. LABT is a small-cap biotech stock trading at $0.75, a price range typical of microcaps with limited liquidity and analyst coverage. Stocks in this category are prone to outsized daily moves driven by several non-news factors: technical chart breakdowns, options expiration activity, short covering reversals, broker downgrades not yet syndicated to major feeds, insider transactions, or clinical trial results posted to company websites before mainstream media pickup. It is also possible that a material development occurred but had not yet reached the Yahoo Finance RSS feed at the time of this analysis. Without more information about LABT's pipeline, recent clinical data, or insider activity, attribution remains speculative.

LUD

Luda Technology Group LimitedBasic Materials

$4.62−$0.69

-13.0%

AMEX · Mkt cap $97 M

LUD fell 13% despite announcing global expansion with new authorized agents across five countries. The negative market reaction to expansion news is counterintuitive and likely reflects investor skepticism about execution, capital requirements, or broader market sentiment unrelated to the announc…

The only headline provided announces Luda Technology's appointment of authorized agents in Brazil, Colombia, Bolivia, Ecuador, and Malaysia to support global expansion. This is typically positioned as positive news signaling growth strategy and market penetration. However, the stock declined 13%, ranking 40th among daily losers. Several possibilities explain this disconnect: the market may view the expansion as capital-intensive without corresponding revenue visibility, doubt the company's ability to execute in emerging markets, or interpret the move as dilutive to near-term profitability. Alternatively, the decline may be entirely unrelated to the expansion announcement—driven by sector-wide weakness, short-covering reversal, broader market volatility, or information not captured in the provided headlines. Without earnings data, guidance, or trading volume context, pinpointing the precise cause remains speculative.

DUOG

Leverage Shares 2x Long DUOL Daily ETF

$35.22−$5.25

-13.0%

NASDAQ

No news headlines were found in the last 48 hours, but DUOG is a 2x leveraged long ETF tracking DUOL, so a roughly 6-7% decline in the underlying would produce this -12.98% loss through amplification.

With no recent news available, the decline cannot be attributed to a specific catalyst affecting DUOG directly. However, DUOG is a daily leveraged product designed to deliver twice the daily return of its underlying index or fund (DUOL). A -12.98% move in a 2x long product is mathematically consistent with approximately a -6% move in the underlying asset. The most likely explanation is that DUOL itself declined sharply today, and DUOG simply amplified that loss as intended by its structure. Without visibility into what drove DUOL lower—whether broad market weakness, sector rotation, geopolitical events, or data releases—the root cause remains unknown, but the ETF is functioning as designed.

AUUD

Auddia Inc.Technology

$1.40−$0.20

-12.5%

NASDAQ · Mkt cap $5.5 M

Auddia announced a parking-lot AI datacenter alternative on May 19, but the market's 12.5% drop suggests investor skepticism about the LT350's commercial viability or concern that the company lacks sufficient revenue traction to justify its valuation.

The only recent headline describes Auddia's promotion of its LT350 parking-lot canopy network as an alternative to traditional AI megacenters, citing a Gallup poll showing 71% of Americans oppose AI datacenters in their communities. This is a positive narrative pitch for the technology. However, the stock fell sharply the next day, which suggests the market either doubts the commercial feasibility of repurposing parking lots at scale, questions management's ability to execute and land customers for this infrastructure model, or interprets the emphasis on an alternative solution as a sign the company has not yet secured major deals. It is also possible the decline is unrelated to this specific announcement and reflects broader sector rotation, short-term trading activity, or other undisclosed developments. Without earnings, guidance, or customer contract announcements, causation remains inferential.

FSHPR

Flag Ship Acquisition Corporation

$0.11−$0.02

-12.4%

NASDAQ

No news headlines were available in the last 48 hours to explain the 12.35% decline. FSHPR, a blank-check acquisition corporation, may have dropped due to typical SPAC-related headwinds, sector rotation, or market-wide pressure on lower-priced equities.

The absence of any news in the provided RSS feeds over the last two days makes direct causation impossible to establish. FSHPR is a special purpose acquisition company (SPAC), a class of security that is particularly sensitive to changes in sentiment toward blank-check mergers, regulatory uncertainty around SPAC structures, and shifts in the broader market appetite for pre-merger stage deals. SPACs trading at or near $0.10 are typically in late-stage redemptions, liquidation considerations, or have exhausted deal timelines. The 12.35% drop could reflect selling pressure tied to deadline approaches, redemption voting, unfavorable market conditions for the SPAC sector, or individual company-specific catalysts not yet reflected in the news feeds captured. Without headlines or structural details about this specific company's status, the exact trigger remains unclear.

PPCB

Propanc Biopharma, Inc.Healthcare

$1.76−$0.25

-12.2%

NASDAQ · Mkt cap $2.6 M

Propanc Biopharma fell 12.22% despite announcing positive clinical progress, including CEO forecasts of breakthroughs and engagement of a European CDMO for Phase 1b manufacturing, suggesting the market may have reacted to specific clinical trial details, funding concerns, or broader biotech secto…

The two most recent headlines announce genuinely constructive developments: the company secured a European Contract Development and Manufacturing Organization for GMP production and the CEO publicly forecasted medical breakthroughs in pancreatic cancer treatment over the next decade, with plans to file a CTA for a Phase 1b study enrolling 30-40 advanced cancer patients in 2026. These are typically positive catalysts for clinical-stage biotech stocks. The sharp 12.22% decline contradicts the narrative in the released news. This disconnect suggests either the market has reacted to information not captured in these headlines (such as disappointing trial data embedded in the full press release, dilutive financing details, or a capital raise announcement), broader sector weakness in biotech equities on the day, or investor skepticism about the clinical pathway despite management's confidence. Without access to the full press release text, earnings, or contemporaneous market conditions, the exact cause remains unclear.

QBTZ

Defiance Daily Target 2X Short QBTS ETF

$15.13−$2.07

-12.0%

NASDAQ

No relevant news headlines were available in the last 48 hours, but the 12% decline in QBTZ is most likely due to a sharp rally in the underlying QBTS ETF, which this inverse leveraged product is designed to decline against.

QBTZ is a daily target 2X short ETF, meaning it is constructed to move inversely and with 2X leverage to its underlying index or asset. When the underlying QBTS ETF rises significantly, QBTZ falls proportionally. Without news headlines provided, the decline cannot be attributed to a specific company or market event affecting QBTZ directly. However, the structure of this security makes it highly sensitive to directional moves in its underlying. A substantial rally in QBTS on May 19 or May 20 would mechanically produce a 12% drop in QBTZ. Leveraged and inverse ETFs are also subject to daily reset mechanics and decay over longer periods, though a single-day move of this magnitude typically reflects underlying price action rather than decay alone.

OFAL

OFA GroupIndustrials

$0.43−$0.06

-12.0%

AMBO

Ambow Education Holding Ltd.Consumer Defensive

$2.51−$0.34

-11.9%

AMEX · Mkt cap $5.9 M

AMBO fell 11.93% on the same day it announced the HybriU Collaboration Board, an AI-powered whiteboard tool, suggesting investors reacted negatively to the product launch or broader market/sentiment headwinds rather than enthusiasm for the new offering.

The only headline available is the May 19 press release announcing HybriU, a phygital collaboration tool for meetings and classrooms. This is a product launch announcement, not negative news in the traditional sense. However, the stock dropped sharply the following trading day. This disconnect suggests either the market viewed the announcement as insufficient or underwhelming relative to expectations, or the decline was driven by factors unrelated to the headline: sector rotation out of edtech, general sell pressure on smaller-cap stocks, a delayed earnings miss, insider selling, short covering reversals, or technical breakdown. Without earnings reports, guidance changes, or negative developments in the headlines, the root cause remains unclear, though the timing suggests the announcement may have disappointed rather than catalyzed buying.

RTB

RTB Digital IncTechnology

$4.60−$0.61

-11.6%

NASDAQ · Mkt cap $181 M

RTB Digital dropped 11.63% on May 20, but the only news in the past 48 hours is a routine announcement of an investor webinar scheduled for May 28, which does not explain the decline.

The provided headline announces a standard investor webinar scheduled for eight days after the price drop, offering no negative catalyst or forward guidance that would trigger an 11.63% sell-off. The timing mismatch rules out this announcement as the cause. RTB Digital is an ad-tech platform company, and declines of this magnitude typically stem from quarterly earnings misses, guidance cuts, loss of major clients, competitive threats, or broader market rotation out of ad-tech or digital-marketing stocks. Without access to earnings reports, analyst downgrades, sector news, or company-specific developments released on May 19–20, we cannot pinpoint the specific trigger. The webinar announcement itself provides no material information that would drive such a sharp decline.

RGTZ

Daily Target 2X Short RGTZ ETF

$12.25−$1.61

-11.6%

NASDAQ

No news was reported in the last 48 hours, but RGTZ is a 2X short ETF, so its 11.6% decline most likely reflects a sharp rally in its underlying stock, which would naturally cause a bearish leveraged short product to fall sharply.

RGTZ is the Daily Target 2X Short ETF on the NASDAQ, meaning it is designed to move inversely to its underlying asset with 2X daily leverage. The absence of any news headlines in the past 48 hours does not explain the move directly; however, the structure of this security provides a clear inference. A daily gain of approximately 6% or more in the underlying stock would produce roughly an 11.6% decline in a 2X short ETF due to inverse and leveraged mechanics. This type of move is typical for inverse leveraged products when their underlying rallies. Without specific news about RGTZ or its underlying, the most probable cause is a strong up day in the referenced asset class, which could stem from broad market strength, sector rotation, positive economic data, or company-specific positive news on the underlying holdings.

REED

Reed's, Inc.Consumer Defensive

$1.69−$0.22

-11.5%

AMEX · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 11.52% decline in REED shares cannot be directly attributed to a specific announced event. The drop likely reflects either a delayed market reaction to prior news, technical selling, or sector-wide headwinds affecting beverage or consumer …

Reed's, Inc. is a small-cap beverage company trading on the AMEX, and the absence of recent news coverage makes it difficult to pinpoint a single catalyst for today's decline. This type of stock—lower-liquidity, consumer-focused—can experience sharp moves on modest volume or delayed reactions to earnings misses, distributor changes, or competitive pressures that may not generate immediate headline coverage. It is also possible the sell-off reflects broader market conditions in consumer staples or discretionary sectors, or accumulated negative sentiment from prior weeks that is only now manifesting in heavier selling. Without access to intraday trading data or insider transaction reports, we cannot distinguish between genuine news-driven weakness and purely technical or momentum-driven selling.